Future challenges: Advancements have been made, but some key issues still remain
Journal of Orthopaedic Research , 24(7), 1421-1432.
Professional care ensures: Safety : Proper technique reduces the risk of side effects
Discuss the benefits and risks with your healthcare provider to determine the best screening schedule, as not all prostate cancers require immediate treatment
This started with the launch of the long-acting/extended release exenatide microspheres, followed by dulaglutide and albiglutide in 2014.10 Interestingly, perhaps the most successful of this wave of once-weekly products, dulaglutide, was launched in a three-step autoinjector, which compared favourably with formulations that required more complicated preparation steps for the user
10.1146/annurev-med-043021-014919 35 JayaramH.KolkoM.FriedmanD